Alexander Lin, MD
Ophthalmology · Honolulu, HINPI 1346668506
Payments from drug & device makers
Across 15 payments — averaging $118.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$274
- Sight Sciences, Inc.$265
- Amgen$259
- Integra Lifesciences Corporation$252
- Axogen$151
- Kls-martin L.p.$130
- plus $440 from 4 others
What the payments were for
- Food & beverage$1,771100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 2 | $274 |
| Sight Sciences, Inc. | 2 | $265 |
| Amgen | 2 | $259 |
| Integra Lifesciences Corporation | 2 | $252 |
| Axogen | 2 | $151 |
| Kls-martin L.p. | 1 | $130 |
| Mallinckrodt Enterprises LLC | 1 | $123 |
| Rxsight Inc | 1 | $120 |
| Novartis | 1 | $110 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $88 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AcrySof$274
- OMNI(R) SURGICAL SYSTEM (US)$265
- BILAYER WOUND MATRIX (BWM)$139
- INTEGRA WOUND MATRIX (IWM)$139
- AMNIOEXCEL$139
- IDRT$139
- FLOWABLE$139
- TEPEZZA$125
- ACTHAR$123
- RXSIGHT CONTACT LENS$120
- RXSIGHT INJECTOR CARTRIDGE$120
- RXSIGHT INJECTOR HANDPIECE$120
- RXSIGHT LIGHT DELIVERY DEVICE (LDD)$120
- RXSIGHT LIGHT ADJUSTABLE LENS (RXLAL)$120
- DURASEAL EXACT SPINAL SEALANT SYSTEM$114
- CODMAN CERTAS$114
How this compares
$1,771 in reported general payments places this provider in the 45th percentile of 120 ophthalmology providers in Hawaii.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RhopressaNetarsudil Mesylate | 28 | $25,068 |
| Prednisolone Acetate | 252 | $14,682 |
| Latanoprost | 752 | $12,919 |
| LumiganBimatoprost | 11 | $8,165 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 326 | $7,874 |
| Dorzolamide Hcl | 158 | $3,808 |
| Cyclosporine | 21 | $3,306 |
| Brimonidine Tartrate | 162 | $3,102 |
| Timolol Maleate | 142 | $3,027 |
| Diclofenac Sodium | 109 | $2,675 |
| ValacyclovirValacyclovir Hcl | 16 | $930 |
| Pilocarpine Hcl | 12 | $508 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 23 | $262 |
| MoxifloxacinMoxifloxacin Hcl | 14 | $205 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Honolulu
- Carlton YuenHonolulu$440K
- Neda NikpoorHonolulu$322K
- Alan FaulknerHonolulu$207K
- Michael BennettHonolulu$190K
- Jeffrey PetersonHonolulu$85K
- Rupa WongHonolulu$72K
- Worldster LeeHonolulu$30K
- Elysse TomHonolulu$20K
- Jon PortisHonolulu$20K
- Tyrie JenkinsHonolulu$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.